spirostans - CISMeF

Preferred Label : spirostans;

MeSH definition : Cholestane derivatives containing a fused lactone ring at the 16,17-position and a spiroglycosidic linkage at C-22. Members include sarsaponin, DIOSGENIN and yamogenin.;

MeSH hyponym : spirostadienes; spirostenes; spirostatrienes; spirostanols;

Is substance : O;

Details

Origin ID

D013150;

UMLS CUI

C0037987;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- spirostadienes [MeSH concept]
- spirostanols [MeSH concept]
- spirostans [MeSH concept]
- spirostatrienes [MeSH concept]
- spirostenes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate [MeSH Supplementary Concept]
- (23S,24R,25S)-23,24-dihydroxyspirost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (23S,25R)-12alpha,17alpha,23-trihydroxyspirost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (23S,25R)-14alpha,17alpha,23-trihydroxyspirost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(12)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (23S,25R)-6alpha-((beta-D-glucopyranosyl)oxy)-23-hydroxy-5alpha-spirostan-3beta -yl beta -D-fucopyranoside [MeSH Supplementary Concept]
- (23S,25R)-spirost-5-en-3beta,23-diol 3-O-(beta-D-xylopyranosyl-(1-2)-O-alpha-L-rhamnopyranosyl-(1-4)-(O-alpha-L-rhamnopyranosyl-(1-2))-beta-D-glucopyranoside) [MeSH Supplementary Concept]
- (25R)-17alpha-hydroxyspitost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1-2)-O-(alpha-L-rhamnopyranosyl-(1-3))-4-O-acetyl-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (25R)-1beta,2alpha-dihydroxy-5alpha-spirostan-3-beta-yl-O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-galactopyranoside [MeSH Supplementary Concept]
- (25R)-1beta,2alpha-dihydroxy-5alpha-spirostan-3-beta-yl-O-beta-D-galactopyranoside [MeSH Supplementary Concept]
- (25S)-5beta-spirostan-3beta-yl-3-O-beta-D-xylopyranosyl(1-3)-O--D-xylopyranosyl(1-4)-beta-D-galactopyranoside [MeSH Supplementary Concept]
- (25S)-ruscogenin 1-sulfate-3-O-alpha-L-rhamnopyranoside [MeSH Supplementary Concept]
- (3beta,5alpha,6beta,25R)-6-((beta-D-glucopyranosyl)oxy)spirostan-3-yl O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3))beta-D-galactopyranoside [MeSH Supplementary Concept]
- 1-O-(2',3'-diacetylfucopyranosyl-(4'-sulfate))-5-spirostan-1-ol 3-acetate [MeSH Supplementary Concept]
- 1-O-(fucopyranosyl-(4'-sulfate))-5-spirostane-1,3-diol [MeSH Supplementary Concept]
- 2,3,23-trihydroxy-5-spirostan-6-one [MeSH Supplementary Concept]
- 2,3-dihydroxy-5-spirostan-6,23-dione [MeSH Supplementary Concept]
- 2,6-dibromospirost-4-ene-3-one [MeSH Supplementary Concept]
- 21-formyl sarsasapogenin [MeSH Supplementary Concept]
- 21-hydroxysarsasapogenin [MeSH Supplementary Concept]
- 21-nor-18,27-dimethyl-1,2,3-trihydroxy-25-spirost-4-en-19-oic acid [MeSH Supplementary Concept]
- 25-spirost-4-ene-3,12-dione [MeSH Supplementary Concept]
- 25-spirostan-3,5,6,19-tetrol [MeSH Supplementary Concept]
- 26-methoxy-spirost-5-en-3-ol-3-O-rhamnopyranosyl-(1-2)-glucopyranoside [MeSH Supplementary Concept]
- 3-(O-beta-D-glucopyranosyl-(1-2)-O-(O-beta-D-glucopyranosyl-(1-4)-O-(O-beta-D-glucopyranosyl-(1-6))-O-beta-D-glucopyranosyl-(1-4)-beta-D-galactopyranosyl)-oxy)-(3beta,5alpha,25R)-spirostane [MeSH Supplementary Concept]
- 3-O-((rhamnopyranosyl-(1-3)-xylopyranosyl-(1-2)-)(glucopyranosyl-(1-3))-glucopyranosyl-(1-3)-glucopyranosyl)spirostan-2,3-diol [MeSH Supplementary Concept]
- 3-O-(quinovopyranosyl(1-6)glucopyranosyl(1-6)glucopyranosyl)chlorogenin [MeSH Supplementary Concept]
- 3-hydroxy-5-spirostan-12-one 3-O-(glucopyranosyl-1-2-(arabinopyranosyl-1-6)glucopyranoside) [MeSH Supplementary Concept]
- 5,6-epoxyspirostan-22-O-3,4-diol [MeSH Supplementary Concept]
- 5,6-epoxyspirostan-22-O-3-ol [MeSH Supplementary Concept]
- 5-spirostan-3-ol 3-O-(glucopyranosyl-1-2-(arabinopyranosyl-1-6)glucopyranoside) [MeSH Supplementary Concept]
- 5alpha-spirostane-12-one-3beta-ol-3-O-beta-xylopyranosyl(1-2)- (beta-xylopyranosyl(1-3))-beta-glucopyranosyl(1-4)-(alpha-rhamno- pyranosyl(1-2))-beta-galactopyranoside [MeSH Supplementary Concept]
- 5alpha-spirostane-3,17,27-triol 3-O-(O-glucopyranosyl-1-2-O-glucopyanosyl-1-4-glucopyranoside) [MeSH Supplementary Concept]
- 5alpha-spirostane-3beta,23,24-triol-3-O-(alpha-L-rhamnopyranosyl-(1 -2))-(beta-D-glucopyranosyl-(1-4)-beta-D-galactopyranoside) [MeSH Supplementary Concept]
- 6alpha-O-(beta-D-xylopyranosyl-(1-3)-beta-D-quinovopyranosyl)-(25S)-5alpha-spirostan-3beta-ol [MeSH Supplementary Concept]
- 6alpha-O-beta-D-quinovopyranosyl-(25S)-5alpha-spirostan-3beta-ol [MeSH Supplementary Concept]
- JNX1001 [MeSH Supplementary Concept]
- JO 475 [MeSH Supplementary Concept]
- L 166143 [MeSH Supplementary Concept]
- PO-1 [MeSH Supplementary Concept]
- PO-2 [MeSH Supplementary Concept]
- POD-II [MeSH Supplementary Concept]
- RCE-4 compound [MeSH Supplementary Concept]
- aferoside A [MeSH Supplementary Concept]
- agaveside A [MeSH Supplementary Concept]
- agaveside B [MeSH Supplementary Concept]
- agaveside C [MeSH Supplementary Concept]
- agaveside D [MeSH Supplementary Concept]
- agigenin [MeSH Supplementary Concept]
- anguivioside A [MeSH Supplementary Concept]
- anguivioside B [MeSH Supplementary Concept]
- anguivioside C [MeSH Supplementary Concept]
- aspafilioside A [MeSH Supplementary Concept]
- aspafilioside B [MeSH Supplementary Concept]
- aspafilioside D [MeSH Supplementary Concept]
- aspaoligonin A [MeSH Supplementary Concept]
- aspaoligonin B [MeSH Supplementary Concept]
- asparacoside [MeSH Supplementary Concept]
- asparacosin A [MeSH Supplementary Concept]
- asparacosin B [MeSH Supplementary Concept]
- barbourgenin [MeSH Supplementary Concept]
- borivilianoside F [MeSH Supplementary Concept]
- borivilianoside G [MeSH Supplementary Concept]
- borivilianoside H [MeSH Supplementary Concept]
- brisbagenin [MeSH Supplementary Concept]
- brisbenone [MeSH Supplementary Concept]
- cantalasaponin 3 [MeSH Supplementary Concept]
- chantrieroside A [MeSH Supplementary Concept]
- chloromaloside A [MeSH Supplementary Concept]
- convallasaponin A [MeSH Supplementary Concept]
- deltonin [MeSH Supplementary Concept]
- dihydroxy-spirostan-12-one 3,6-di-O-glucopyranoside [MeSH Supplementary Concept]
- diurnoside 1 [MeSH Supplementary Concept]
- dongnoside A [MeSH Supplementary Concept]
- dongnoside B [MeSH Supplementary Concept]
- epismilagenin glucuronide [MeSH Supplementary Concept]
- floribundasaponin D [MeSH Supplementary Concept]
- foliumin [MeSH Supplementary Concept]
- furcreastatin [MeSH Supplementary Concept]
- gitogenin [MeSH Supplementary Concept]
- gitogenin 3-O-(O-glucopyranosyl-(1-2)-O-(O-rhamnopyranosyl-(1-4)-xylopyranosyl-(1-3))-O-glucopyranosyl-(1-4)-galactopyranoside) [MeSH Supplementary Concept]
- gitogenin 3-O-(O-glucopyranosyl-(1-2)-O-(xylopyranosyl-(1-3))-O-glucopyranosyl-(1-4)-galactopyranoside) [MeSH Supplementary Concept]
- glucopyranosyl-(1-3)-deltonin [MeSH Supplementary Concept]
- gracillin [MeSH Supplementary Concept]
- indioside F [MeSH Supplementary Concept]
- laxogenin [MeSH Supplementary Concept]
- laxumin A [MeSH Supplementary Concept]
- melongoside F [MeSH Supplementary Concept]
- namogenin A [MeSH Supplementary Concept]
- namogenin B [MeSH Supplementary Concept]
- namogenin C [MeSH Supplementary Concept]
- neoruscogenin [MeSH Supplementary Concept]
- nigrumnin I [MeSH Supplementary Concept]
- nigrumnin II [MeSH Supplementary Concept]
- nocturnoside A [MeSH Supplementary Concept]
- nummularogenin [MeSH Supplementary Concept]
- ophiopogonin B [MeSH Supplementary Concept]
- ophiopogonin D [MeSH Supplementary Concept]
- ophiopogonin F [MeSH Supplementary Concept]
- ophiopogonin G [MeSH Supplementary Concept]
- pennogenin tetraglycoside [MeSH Supplementary Concept]
- rockogenin [MeSH Supplementary Concept]
- ruizgenin [MeSH Supplementary Concept]
- ruscogenin [MeSH Supplementary Concept]
- ruscogenin-1-yl xylopyranosyl-1-3-(glucopyranosyl-1-2)fucopyranoside [MeSH Supplementary Concept]
- ruscorectal (combination) [MeSH Supplementary Concept]
- sansevierin A [MeSH Supplementary Concept]
- sansevistatin 1 [MeSH Supplementary Concept]
- sansevistatin 2 [MeSH Supplementary Concept]
- sarsasapogenin [MeSH Supplementary Concept]
- sarsasapogenone [MeSH Supplementary Concept]
- smilageninoside [MeSH Supplementary Concept]
- smilaxin B [MeSH Supplementary Concept]
- soladulcoside A [MeSH Supplementary Concept]
- soladulcoside B [MeSH Supplementary Concept]
- solalyratine A [MeSH Supplementary Concept]
- solalyratine B [MeSH Supplementary Concept]
- spirost-5-ene-1,3,14,15-tetrol [MeSH Supplementary Concept]
- spirost-5-ene-3,17,27-triol 3-O-(O-glucopyranosyl-1-2-O-glucopyranosyl-1-4-glucopyranoside) [MeSH Supplementary Concept]
- spirost-5-ene-3,23-diol-23-O-(O-glucopyranosyl-(1-6)-glucopyranoside) [MeSH Supplementary Concept]
- thibetanoside A [MeSH Supplementary Concept]
- thibetanoside B [MeSH Supplementary Concept]
- thibetanoside C [MeSH Supplementary Concept]
- tigogenin hexasaccharide-1 [MeSH Supplementary Concept]
- tigogenin hexasaccharide-2 [MeSH Supplementary Concept]
- torvoside J [MeSH Supplementary Concept]
- torvoside K [MeSH Supplementary Concept]
- torvoside L [MeSH Supplementary Concept]
- tuberoside D [MeSH Supplementary Concept]
- tuberoside E [MeSH Supplementary Concept]
- tupichigenin B [MeSH Supplementary Concept]
- tupichigenin C [MeSH Supplementary Concept]
- tupichinin A [MeSH Supplementary Concept]
- tupichinin B [MeSH Supplementary Concept]
- tupichinin C [MeSH Supplementary Concept]
- tupichinin D [MeSH Supplementary Concept]
- uttronin A [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients